Onkos Surgical, Inc. — SEC Form D Filing

Onkos Surgical, Inc. filed an SEC Form D on August 7, 2026, reporting $37.25M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
August 7, 2026
Amount reported
$37.25M
Industry
Medical Devices
Website
https://onkossurgical.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Individuals with cancer and other complex orthopedic conditions require specialized solutions. Complex resection and reconstruction of long bones or the pelvis present challenges for surgeons.

Solution

Onkos Surgical provides precision orthopaedics, including antibacterial implant technology (NanoCept®), limb salvage systems (ELEOS™) to address soft tissue and implant loosening failures, personalized 3D solutions (My3D®) for reconstruction and joint preservation, and extendible prostheses (JTS) for pediatric bone tumor surgery.

Verdict

Investors backed this round because the company presented a specialized, integrated suite of orthopedic solutions for a complex, high-stakes medical niche, not because it offered a broad-market disruptive technology. They were implicitly betting on the steady adoption of purpose-built devices in oncology-driven orthopedics, where clinical outcomes outweigh minor cost differentials. Upside was limited by the inherently smaller patient population and the necessity of navigating complex regulatory pathways for each specialized device.

Source: SEC EDGAR Form D filing